MARKET COMPOSITE
BDX - Becton, Dickinson And Co.8:00:02 PM 4/19/2024
Price
$234.12
+ 0.97 (0.42%)
Becton, Dickinson and Company, commonly known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 70,000 people in more than 50 countries throughout the world. In the fiscal year ending September 30, 2019, more than 40% of BD sales were generated from non-U.S. markets.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue4.7B-7%
Gross Profit2B-
Cost Of Revenue2.7B-21%
Operating Income439MM+26%
Operating Expenses1.6B-
Net Income281MM-
R&D290MM+3%
G&A1.2B+7%
Amortization365MM-1%
Interest Expense111MM-2%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    BDX vs. MMSI: Which Stock Is the Better Value Option?

    Madison Investments, an investment advisor, released its “Madison Investors Fund” first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund (Class Y) returned 9.63% compared to a 10.56% return for the S&P 500 index. The business remains dedicated to its more than two-decades-old strategy of investing in […]

    BD's (BDX) slew of product launches and strategic deals raises optimism about the stock.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.

    The latest worldwide commercial availability of BD's (BDX) cell sorters is set to expand researchers' capabilities to transform research and cell-based therapeutic development across numerous fields.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's second quarter

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

    Looking for Dividend aristocrats trading at their 52-week lows? If so, you’ve come to the right place. Investing shouldn’t always be about chasing high-flying stocks. Sometimes, the best picks can be those hiding in plain sight. A contrarian view might give you a once-in-a-decade opportunity to own a top-tier stock. I can’t blame investors for rushing to the exit when stocks are in free fall. However, prudent investors know that downturns can be great opportunities to snag quality stocks at a ba

    BDX vs. MMSI: Which Stock Is the Better Value Option?